CDXS Codexis Inc

USD 3.68 0.13 3.661972
Icon

Codexis Inc (CDXS) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 3.68

+0.13 (+3.66)%

USD 0.23B

0.64M

USD 8.33(+126.45%)

N/A

Icon

CDXS

Codexis Inc (USD)
COMMON STOCK | NSD
USD 3.68
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.23B

N/A

USD 3.68

Codexis Inc (CDXS) Stock Forecast

Show ratings and price targets of :
USD 8.33
(+126.45%)

Based on the Codexis Inc stock forecast from 3 analysts, the average analyst target price for Codexis Inc is USD 8.33 over the next 12 months. Codexis Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Codexis Inc is Bearish, which is based on 1 positive signals and 7 negative signals. At the last closing, Codexis Inc’s stock price was USD 3.68. Codexis Inc’s stock price has changed by +12.54% over the past week, +25.17% over the past month and -1.87% over the last year.

No recent analyst target price found for Codexis Inc
No recent average analyst rating found for Codexis Inc

Company Overview Codexis Inc

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company operates through two segments, Performance Enzymes and Novel Biotherapeutics. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering ...Read More

https://www.codexis.com

200 Penobscot Drive, Redwood City, CA, United States, 94063

174

December

USD

USA

Adjusted Closing Price for Codexis Inc (CDXS)

Loading...

Unadjusted Closing Price for Codexis Inc (CDXS)

Loading...

Share Trading Volume for Codexis Inc Shares

Loading...

Compare Performance of Codexis Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for CDXS

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Codexis Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc +4.34 (+0.88%) USD126.85B 31.94 20.00

ETFs Containing CDXS

Symbol Name CDXS's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Codexis Inc (CDXS) Stock

Based on ratings from 3 analysts Codexis Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 3 buy, sell and hold ratings.

Unfortunately we do not have enough data on CDXS's stock to indicate if its a good dividend stock.

Based on targets from 3 analysts, the average taret price for CDXS is USD 8.33 over the next 12 months. The maximum analyst target price is USD 11 while the minimum anlayst target price is USD 5.

Unfortunately we do not have enough data on CDXS's stock to indicate if its overvalued.

The last closing price of CDXS's stock was USD 3.68.

The most recent market capitalization for CDXS is USD 0.23B.

Based on targets from 3 analysts, the average taret price for CDXS is projected at USD 8.33 over the next 12 months. This means that CDXS's stock price may go up by +126.45% over the next 12 months.

We can't find any ETFs which contains Codexis Inc's stock.

As per our most recent records Codexis Inc has 174 Employees.

Codexis Inc's registered address is 200 Penobscot Drive, Redwood City, CA, United States, 94063. You can get more information about it from Codexis Inc's website at https://www.codexis.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...